![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Spain Locks in 31.5 Million Doses of AstraZeneca’s COVID-19 Vaccine
Spain Locks in 31.5 Million Doses of AstraZeneca’s COVID-19 Vaccine
The Spanish government announced that it has authorized the purchase of 31.5 million doses of AstraZeneca’s COVID-19 vaccine.
Spain will pay an estimated $90 million upon delivery of the doses, which will occur between December and June 2021. The acquisition is part of a larger deal negotiated by the European Commission that netted EU member states a total of 300 million doses of the vaccine candidate for approximately $1 billion.
Because immunization with the vaccine requires two doses, the country will now be able to vaccinate approximately 15.75 million patients with the stock of AZD1222. Spain has a population of almost 47 million.
Upcoming Events
-
21Oct